P V Kirjavainen

Summary

Affiliation: University of Turku
Country: Finland

Publications

  1. ncbi Probiotic bacteria in the management of atopic disease: underscoring the importance of viability
    Pirkka V Kirjavainen
    Department of Biochemistry and Food Chemistry, University of Turku, FIN 20014 Turku, Finland
    J Pediatr Gastroenterol Nutr 36:223-7. 2003
  2. ncbi Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning?
    P V Kirjavainen
    Department of Biochemistry and Food Chemistry, University of Turku, Finland
    Gut 51:51-5. 2002
  3. ncbi In vitro adhesion and platelet aggregation properties of bacteremia-associated lactobacilli
    P V Kirjavainen
    Department of Biochemistry and Food Chemistry, University of Turku, Turku, Finland
    Infect Immun 67:2653-5. 1999
  4. ncbi Healthy gut microflora and allergy: factors influencing development of the microbiota
    P V Kirjavainen
    Department of Biochemistry and Food Chemistry, University of Turku, Finland
    Ann Med 31:288-92. 1999
  5. ncbi The effect of orally administered viable probiotic and dairy lactobacilli on mouse lymphocyte proliferation
    P V Kirjavainen
    Key Centre for Applied and Nutritional Toxicology, RMIT University, Melbourne, Vic, Australia
    FEMS Immunol Med Microbiol 26:131-5. 1999
  6. ncbi Effects of orally administered viable Lactobacillus rhamnosus GG and Propionibacterium freudenreichii subsp. shermanii JS on mouse lymphocyte proliferation
    P V Kirjavainen
    Key Centre for Applied and Nutritional Toxicology, RMIT University, Melbourne, Victoria, Australia
    Clin Diagn Lab Immunol 6:799-802. 1999
  7. ncbi Characterizing the composition of intestinal microflora as a prospective treatment target in infant allergic disease
    P V Kirjavainen
    Department of Biochemistry and Food Chemistry, University of Turku, Turku, Finland
    FEMS Immunol Med Microbiol 32:1-7. 2001
  8. ncbi Good adhesion properties of probiotics: a potential risk for bacteremia?
    E Apostolou
    Department of Biochemistry and Food Chemistry, University of Turku, Finland
    FEMS Immunol Med Microbiol 31:35-9. 2001
  9. ncbi The ability of probiotic bacteria to bind to human intestinal mucus
    P V Kirjavainen
    Department of Biochemistry and Food Chemistry, University of Turku, Finland
    FEMS Microbiol Lett 167:185-9. 1998
  10. ncbi Differences in the gut bacterial flora of healthy and milk-hypersensitive adults, as measured by fluorescence in situ hybridization
    E Apostolou
    Department of Biochemistry and Food Chemistry, FIN-20014 University of Turku, Finland
    FEMS Immunol Med Microbiol 30:217-21. 2001

Collaborators

Detail Information

Publications13

  1. ncbi Probiotic bacteria in the management of atopic disease: underscoring the importance of viability
    Pirkka V Kirjavainen
    Department of Biochemistry and Food Chemistry, University of Turku, FIN 20014 Turku, Finland
    J Pediatr Gastroenterol Nutr 36:223-7. 2003
    ..The aim of this study was to assess the efficacy of oral supplementation of viable and heat-inactivated probiotic bacteria in the management of atopic disease and to observe their effects on the composition of the gut microbiota...
  2. ncbi Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning?
    P V Kirjavainen
    Department of Biochemistry and Food Chemistry, University of Turku, Finland
    Gut 51:51-5. 2002
    ..Recent data have outlined a relationship between the composition of the intestinal microflora and allergic inflammation, and demonstrated the competence of probiotics in downregulation of such inflammation...
  3. ncbi In vitro adhesion and platelet aggregation properties of bacteremia-associated lactobacilli
    P V Kirjavainen
    Department of Biochemistry and Food Chemistry, University of Turku, Turku, Finland
    Infect Immun 67:2653-5. 1999
    ..In conclusion, strong binding ability does not appear to be a prerequisite for the involvement of lactobacilli in bacteremia or to their ability to aggregate platelets...
  4. ncbi Healthy gut microflora and allergy: factors influencing development of the microbiota
    P V Kirjavainen
    Department of Biochemistry and Food Chemistry, University of Turku, Finland
    Ann Med 31:288-92. 1999
    ....
  5. ncbi The effect of orally administered viable probiotic and dairy lactobacilli on mouse lymphocyte proliferation
    P V Kirjavainen
    Key Centre for Applied and Nutritional Toxicology, RMIT University, Melbourne, Vic, Australia
    FEMS Immunol Med Microbiol 26:131-5. 1999
    ..Therefore, these Lactobacillus strains demonstrate strain-specific effects on B- and T-cells and may also alter the splenocyte sensitivity to the cytotoxic effects of mitogens...
  6. ncbi Effects of orally administered viable Lactobacillus rhamnosus GG and Propionibacterium freudenreichii subsp. shermanii JS on mouse lymphocyte proliferation
    P V Kirjavainen
    Key Centre for Applied and Nutritional Toxicology, RMIT University, Melbourne, Victoria, Australia
    Clin Diagn Lab Immunol 6:799-802. 1999
    ..In conclusion, LGG and PJS have specific dose- and duration-dependent immunomodulatory effects on the proliferative activity of B and T lymphocytes and may also reduce lymphocyte sensitivity to the cytotoxic effects of lectin mitogens...
  7. ncbi Characterizing the composition of intestinal microflora as a prospective treatment target in infant allergic disease
    P V Kirjavainen
    Department of Biochemistry and Food Chemistry, University of Turku, Turku, Finland
    FEMS Immunol Med Microbiol 32:1-7. 2001
    ..In conclusion, the most prominent question raised by these data is whether Gram-positive bacteria may have distinctive importance in protection against atopic sensitization. Further studies aiming to answer this question are warranted...
  8. ncbi Good adhesion properties of probiotics: a potential risk for bacteremia?
    E Apostolou
    Department of Biochemistry and Food Chemistry, University of Turku, Finland
    FEMS Immunol Med Microbiol 31:35-9. 2001
    ....
  9. ncbi The ability of probiotic bacteria to bind to human intestinal mucus
    P V Kirjavainen
    Department of Biochemistry and Food Chemistry, University of Turku, Finland
    FEMS Microbiol Lett 167:185-9. 1998
    ..In conclusion, the age of the target group may be worthy of consideration when planning a schedule for probiotic or functional food therapy...
  10. ncbi Differences in the gut bacterial flora of healthy and milk-hypersensitive adults, as measured by fluorescence in situ hybridization
    E Apostolou
    Department of Biochemistry and Food Chemistry, FIN-20014 University of Turku, Finland
    FEMS Immunol Med Microbiol 30:217-21. 2001
    ..In conclusion, the composition of the gut microbiota in milk-hypersensitive adults appears to be normal. LGG may have potential in reinforcing the endogenous flora...
  11. ncbi Adhesion of four Bifidobacterium strains to human intestinal mucus from subjects in different age groups
    A C Ouwehand
    Department of Biochemistry and Food Chemistry, University of Turku, Finland
    FEMS Microbiol Lett 172:61-4. 1999
    ..The results suggest that reduced adhesion may be a factor involved in the decreasing colonisation of elderly subjects by bifidobacteria...
  12. ncbi The mucus binding of Bifidobacterium lactis Bb12 is enhanced in the presence of Lactobacillus GG and Lact. delbrueckii subsp. bulgaricus
    A C Ouwehand
    Department of Biochemistry and Food Chemistry, University of Turku, Finland
    Lett Appl Microbiol 30:10-3. 2000
    ..The results suggest that combinations of probiotics strains may have synergistic adhesion effects. Such specific strain combinations should also be assessed in clinical studies...
  13. ncbi Probiotics: a role in the treatment of intestinal infection and inflammation?
    E Isolauri
    Department of Paediatrics, University of Turku, Finland
    Gut 50:III54-9. 2002
    ..Realisation of this has led to the introduction of novel modes of therapeutic and prophylactic intervention based on the consumption of mono and mixed cultures of beneficial live microorganisms as probiotics...